Results 241 to 250 of about 3,048,170 (258)

Functional Specialization of Clathrin‐Independent Endocytic Routes: Mechanisms and Cellular Roles

Traffic, Volume 27, Issue 3, September 2026.
Distinct clathrin‐independent endocytic (CIE) routes support specialized cellular functions across different contexts. Created with Biorender.com. ABSTRACT Clathrin‐independent endocytosis (CIE) comprises a diverse repertoire of internalization mechanisms that operate in parallel with clathrin‐mediated endocytosis.
Andrea Francesco Benvenuto, Amir Fardin, Matteo Balestra, Pier Paolo Di Fiore, Chiara Tordonato, Sara Sigismund   +5 more
wiley   +1 more source

Geographic and genetic diversity in gallbladder cancer mutation profiles: insights from a worldwide exome analysis. [PDF]

EBioMedicine
Gárate-Calderón V, Kumar R, Marcelain K, Zollner L, Boekstegers F, Barajas O, Loader D, Rivera MT, Morales E, de Toro G, Caglevic C, Shibata T, Lorenzo Bermejo J.   +12 more
europepmc   +1 more source

Retrospective Analysis of Survival and Adverse Effects Associated With Stereotactic Body Radiation Therapy in 12 Dogs With Hepatocellular Carcinoma

Veterinary and Comparative Oncology, Volume 24, Issue 3, Page 485-498, September 2026.
ABSTRACT This retrospective analysis evaluated 12 dogs with hepatocellular carcinoma (HCC) who received stereotactic body radiation therapy (SBRT). Dogs received between 6 and 25 Grey (Gy) per fraction for 1–5 fractions for a total dose of 13–30 Gy. Eleven patients (92%) experienced acute adverse effects (AE), with the majority being VRTOG grade 2–3 ...
Victoria Lee Newberry, Mary‐Keara Boss, Del Leary, Tiffany W. Martin   +3 more
wiley   +1 more source

Sarcoidosis gallbladder involvement mimicking gallbladder cancer: a case report and review of the literature. [PDF]

Int J Surg Case Rep
Nada E, Mohamed H, Zied H, Fadhel A, Sahir O, Dhouha B.   +5 more
europepmc   +1 more source

Case Report: Successful conversion of gallbladder cancer with intrahepatic metastases using camrelizumab combined with gemcitabine and cisplatin. [PDF]

Front Immunol
Wang D, Li Y, Shi G, Wang W, Ma T, Mi C, Du Y, Wang S, Sheng X, Wang L, Xu X, Wang Y, Yang H.   +12 more
europepmc   +1 more source

Application of robotic-assisted hepatopancreatoduodenectomy in non-jaundiced gallbladder cancer patient with invasion of the common bile duct: A case report. [PDF]

Medicine (Baltimore)
Xu K, Chen G, Liu C, Li W, Li X, Cao G, Zhang L, Tang J, Yi C, Xue F, Liang L, Cao D, Wang B.   +12 more
europepmc   +1 more source

Exploring the efficacy of XAV939 and LF3 in targeting β-catenin signalling in gallbladder cancer cell lines. [PDF]

Discov Oncol
Kashyap A, Umar SM, Dev AJR, Manav N, Das P, Kumar S, Chethan R, Prasad CP.   +7 more
europepmc   +1 more source

From Anatomical Staging to Precision Prognostication: Evolution of Gallbladder Cancer Staging Across AJCC Editions and the 2025 UICC TNM Update. [PDF]

J Pers Med
Shen T, Tan NKY, Chew WX, Liau MYQ, Luvira V, Kapoor VK, Ioannidis O, Shelat VG.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions

Cancers, 2022
Felix Huttner, Thomas J Ettrich
exaly  

Epidemiology and Molecular Pathology of Gallbladder Cancer

Ca-A Cancer Journal for Clinicians, 2001
Flavio Nervi, E C Lazcano-Ponce
exaly